Cells have emerged as a promising new form of drug delivery carriers owing to their
distinguished advantages such as naturally bypassing immune recognition, intrinsic …

Cell primitive-based functional materials that combine the advantages of natural substances
and nanotechnology have emerged as attractive therapeutic agents for cancer therapy. Cell …

Nanomaterials are promising carriers to improve the bioavailability and therapeutic
efficiency of drugs by providing preferential drug accumulation at their sites of action, but …

Despite great efforts and advancement in the treatment of cancer, tumor recurrence and
metastasis remain significant challenges and demand novel therapy strategies. Recently …

Radiation therapy (RT) provides therapeutic benefits for patients with glioblastoma (GBM),
but inevitably induces poorly understood global changes in GBM and its microenvironment …

Surgery remains a primary modality of treatment for the majority of solid tumor malignancies.
While advancements in surgical technique and instrumentation have improved the quality of …

Glioblastoma ranks among the most lethal of all human cancers. Glioblastomas display
striking cellular heterogeneity, with stem-like glioblastoma stem cells (GSCs) at the apex …

Cell therapy has already had an important impact on healthcare and provided new
treatments for previously intractable diseases. Notable examples include mesenchymal …

Introduction Drug delivery to solid tumors remains a significant therapeutic challenge.
Mesenchymal stem/stromal cells (MSCs) home to tumor tissues and can be employed as …

Spurred by numerous achievements in nanoscience and nanotechnology, the evolution of
nanoparticulate drug delivery systems (nano-DDSs) is in its rapid growth period and …